TNDM Tandem Diabetes Care, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

TNDM [NASD]

Tandem Diabetes Care, Inc.

Healthcare | Medical Devices | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.28	Insider Own	4.39%	Shs Outstand	59.74M	Perf Week	-5.71%
Market Cap	5.84B	Forward P/E	3551.48	EPS next Y	0.03	Insider Trans	-11.11%	Shs Float	57.03M	Perf Month	20.65%
Income	-16.60M	PEG	-	EPS next Q	-0.24	Inst Own	94.90%	Short Float	6.67%	Perf Quarter	44.33%
Sales	394.20M	P/S	14.81	EPS this Y	83.40%	Inst Trans	0.19%	Short Ratio	2.93	Perf Half Y	42.59%
Book/sh	3.47	P/B	27.63	EPS next Y	106.00%	ROA	-5.50%	Target Price	100.38	Perf Year	50.53%
Cash/sh	2.63	P/C	36.45	EPS next 5Y	-	ROE	-9.30%	52W Range	43.69 - 106.18	Perf YTD	60.86%
Dividend	-	P/FCF	11677.48	EPS past 5Y	58.50%	ROI	-8.70%	52W High	-8.14%	Beta	0.55
Dividend %	-	Quick Ratio	2.20	Sales past 5Y	48.80%	Gross Margin	53.60%	52W Low	123.25%	ATR	5.02
Employees	1043	Current Ratio	2.80	Sales Q/Q	48.30%	Oper. Margin	-4.90%	RSI (14)	57.52	Volatility	5.06% 5.77%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	37.50%	Profit Margin	-4.20%	Rel Volume	0.72	Prev Close	95.89
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Jul 30 AMC	Payout	-	Avg Volume	1.30M	Price	97.54
Recom	2.20	SMA20	4.84%	SMA50	11.46%	SMA200	36.38%	Volume	922,394	Change	1.72%

Jul-06-20

Upgrade

Citigroup

Neutral → Buy

$120

Jun-18-20

Reiterated

Raymond James

Outperform

$88 → $95

Apr-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Mar-23-20

Downgrade

Guggenheim

Buy → Neutral

Mar-05-20

Initiated

Citigroup

Neutral

$89

Feb-06-20

Initiated

Raymond James

Outperform

Feb-04-20

Downgrade

Robert W. Baird

Outperform → Neutral

$75

Oct-18-19

Initiated

Guggenheim

Buy

$76

Oct-04-19

Upgrade

UBS

Neutral → Buy

$75

May-17-19

Reiterated

BofA/Merrill

Neutral

$65 → $75

May-13-19

Initiated

SVB Leerink

Outperform

$83

Mar-08-19

Initiated

BMO Capital Markets

Outperform

$77

Mar-05-19

Reiterated

BofA/Merrill

Neutral

$59 → $65

Feb-27-19

Reiterated

Lake Street

Buy

$60 → $100

Nov-21-18

Upgrade

Robert W. Baird

Neutral → Outperform

Sep-26-18

Reiterated

Piper Jaffray

Overweight

$32 → $56

Sep-26-18

Reiterated

Dougherty & Company

Buy

$45 → $56

Sep-14-18

Downgrade

Robert W. Baird

Outperform → Neutral

Aug-30-18

Initiated

Berenberg

Buy

$50

Aug-24-18

Upgrade

BofA/Merrill

Underperform → Neutral

$45

Jul-12-20 01:30PM	Did Hedge Funds Make The Right Call On Tandem Diabetes Care Inc (TNDM) ? Insider Monkey
Jul-09-20 09:00AM	Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement Business Wire
Jul-08-20 09:00AM	JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community Business Wire
Jul-07-20 04:05PM	Tandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020 Business Wire
Jul-06-20 04:03PM	Abbott Deal, UnitedHealth Coverage Push Up Tandem Shares GuruFocus.com
Jun-30-20 02:31PM	Abbott, Tandem Diabetes Seal Deal on Diabetes Management Zacks +12.65%
Jun-29-20 01:59PM	Edited Transcript of TNDM.OQ earnings conference call or presentation 30-Apr-20 8:30pm GMT Thomson Reuters StreetEvents
09:00AM	Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems PR Newswire
Jun-25-20 10:34AM	Tandem Diabetes' Sugarmate Buyout Boosts Digital Offerings Zacks
Jun-24-20 09:00AM	Tandem Diabetes Care Acquires Sugarmate, a Popular Mobile App for People with Diabetes Business Wire
Jun-18-20 10:13AM	Tandem Diabetes Gets Expanded Indication for Insulin Pump Zacks
09:38AM	Tandem Diabetes (TNDM) Looks Good: Stock Adds 6.5% in Session Zacks
Jun-17-20 09:00AM	Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology Business Wire +6.54%
Jun-16-20 09:28AM	Robinhood traders could learn from this growth-stock investor whos beaten indexes by a wide margin for years MarketWatch
Jun-13-20 11:01AM	Tandem Diabetes Care Presents Positive Real-world Data from Automated Insulin Delivery Systems at American Diabetes Association Scientific Sessions Business Wire
Jun-08-20 02:26AM	Is Tandem Diabetes Care Inc (TNDM) A Good Stock To Buy? Insider Monkey
Jun-04-20 09:15AM	Tandem Diabetes Care Appoints Dr. Kathleen McGroddy-Goetz to Board of Directors Business Wire -5.50%
Jun-02-20 11:11AM	Tandem Diabetes Rides on Control-IQ Amid Coronavirus Crisis Zacks
10:30AM	Here's Why You Should Hold on to Tandem Diabetes Stock for Now Zacks
May-29-20 04:05PM	Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations Business Wire
May-23-20 08:00AM	Teladoc, Neurocrine Bio Lead Five Healthy Stocks To Monitor Closely Investor's Business Daily
May-18-20 04:15PM	Tandem Diabetes Care to Hold Virtual-Only 2020 Annual Meeting of Stockholders Business Wire
May-17-20 12:27PM	2 Top Diabetes Stocks to Buy in May Motley Fool
May-13-20 01:25AM	Tandem Diabetes Care Announces Pricing of $250.0 Million of Convertible Senior Notes Due 2025 Business Wire
May-12-20 07:10AM	Tandem Diabetes Care Announces Proposed Offering of $250.0 Million of Convertible Senior Notes Due 2025 Business Wire
May-07-20 04:05PM	Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations Business Wire
May-05-20 11:00AM	Tandem Diabetes (TNDM) Q1 Loss Widens, Revenues Top Estimates Zacks
May-01-20 04:01PM	Tandem Diabetes Care Inc (TNDM) Q1 2020 Earnings Call Transcript Motley Fool
Apr-30-20 04:05PM	Tandem Diabetes Care Announces First Quarter 2020 Financial Results Business Wire +6.99%
Apr-29-20 12:57PM	Will Tandem Diabetes Care Experience a COVID-19 Slowdown? Motley Fool +6.24%
Apr-21-20 12:03PM	Here's Why You Should Add Tandem Diabetes to Your Portfolio Zacks
Apr-09-20 04:05PM	Tandem Diabetes Care to Announce First Quarter 2020 Financial Results on April 30, 2020 Business Wire
Mar-27-20 11:38AM	Hedge Funds Have Never Been This Bullish On Tandem Diabetes Care Inc (TNDM) Insider Monkey
Mar-26-20 06:43PM	Stocks Showing Improving Market Leadership: Tandem Diabetes Care Earns 82 RS Rating Investor's Business Daily +13.32%
Mar-16-20 04:05PM	Tandem Diabetes Care Announces Security Incident with Five Employee Email Accounts Business Wire -16.13%
Mar-12-20 10:23AM	Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now Zacks -11.19%
Mar-06-20 07:55AM	Edited Transcript of TNDM earnings conference call or presentation 24-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Mar-03-20 03:19PM	Tandem Diabetes Wins FDA's iAGC Designation for Basal-IQ Zacks
Mar-02-20 09:00AM	Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller Business Wire +5.49%
Feb-28-20 04:30PM	TNDM Stock Exit Preceded Stock Market Correction Investor's Business Daily
12:36PM	Tandem Diabetes Care, Inc. Released Earnings Last Week And Analysts Lifted Their Price Target To US$94.00 Simply Wall St.
Feb-25-20 08:46AM	Tandem Diabetes (TNDM) Q4 Earnings Beat Estimates, Margins Up Zacks -10.20%
08:33AM	Zacks.com featured highlights include: International Money Express, Tandem Diabetes Care, Kirkland Lake Gold and USANA Health Sciences Zacks
Feb-24-20 05:42PM	Leading Diabetes Outlet Flounders Despite Unexpected Profit As Sales Lag Investor's Business Daily
04:05PM	Tandem Diabetes Care Announces Fourth Quarter and Full Year 2019 Financial Results and 2020 Financial Guidance Business Wire
Feb-21-20 05:00PM	Why This Diabetes Stock Could Sprint In 2020 On Medtronic's Setback Investor's Business Daily
04:19PM	Why This Diabetes Stock Could Sprint In 2020 On Medtronic's Setback Investor's Business Daily
08:59AM	Should You Buy Tandem Diabetes Care (TNDM) Ahead of Earnings? Zacks
Feb-20-20 12:15PM	Data Presented at International Diabetes Conference Further Demonstrate Benefits of Tandem Diabetes Care Automated Insulin Delivery Technologies Business Wire
Feb-18-20 03:05PM	Tandem Diabetes Hits New 52-Week High: What's Driving It? Zacks
Feb-14-20 04:05PM	Tandem Diabetes Care Announces Upcoming Conference Presentations Business Wire
Feb-13-20 12:48PM	4 Momentum Stocks To Watch Benzinga
08:34AM	Are Options Traders Betting on a Big Move in Tandem Diabetes (TNDM) Stock? Zacks
Feb-11-20 06:45AM	Will Tandem Diabetes Care Continue to Surge Higher? Zacks
Feb-10-20 09:47AM	Can Pharmacy Services Growth Aid CVS Health (CVS) Q4 Earnings? Zacks +6.23%
08:26AM	DexCom (DXCM) to Report Q4 Earnings: What's in the Cards? Zacks
07:54AM	Cannabis Therapy to Drive Canopy Growth's (CGC) Q3 Earnings Zacks
05:00AM	Shifting Trends in Diabetes Monitoring Boost Dexcom and Tandem MoneyShow
Feb-07-20 10:56AM	Molina Healthcare (MOH) to Post Q4 Earnings: What to Expect Zacks
10:52AM	What's in the Offing for LabCorp's (LH) Earnings in Q4? Zacks
Feb-04-20 11:44AM	What's in the Cards for Exact Sciences' (EXAS) Q4 Earnings? Zacks
Feb-03-20 09:44AM	Is a Beat in the Cards for Humana's (HUM) Earnings in Q4? Zacks
Jan-31-20 10:10AM	The Zacks Analyst Blog Highlights: Agilysys, Tandem Diabetes Care, Enphase Energy, Forterra and MagnaChip Semiconductor Zacks
Jan-30-20 07:18AM	5 Top-Ranked Growth Stocks for February That Have Jumped YTD Zacks
Jan-29-20 05:18PM	This IBD Stock Of The Day Broke Out And Is Now Eyeing Profitability Investor's Business Daily +9.07%
11:01AM	Can Solid IC Growth Aid Boston Scientific (BSX) Q4 Earnings? Zacks
08:36AM	What's in the Cards for Zimmer Biomet (ZBH) in Q4 Earnings? Zacks
Jan-28-20 07:34AM	Zacks.com featured highlights include: Synaptics, MagnaChip Semiconductor, Tandem Diabetes Care and International Money Express Zacks
Jan-27-20 04:05PM	Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020 Business Wire
11:40AM	Moving Average Crossover Alert: Tandem Diabetes Care Zacks
09:25AM	Check 4 Best Liquid Bets to Power Your Portfolio Zacks
09:11AM	What's in Store for Thermo Fisher (TMO) in Q4 Earnings? Zacks
Jan-24-20 09:06AM	Can Critical Care Aid Edwards Lifesciences (EW) Q4 Earnings? Zacks
08:48AM	Can Sequencing Products Aid Illumina (ILMN) in Q4 Earnings? Zacks
Jan-23-20 10:45AM	Will New Buyouts Aid Quest Diagnostics (DGX) Q4 Earnings? Zacks
09:54AM	Moving Average Crossover Alert: Tandem Diabetes Care Zacks
09:17AM	Will Segmental Growth Aid Hologic (HOLX) in Q1 Earnings? Zacks
Jan-20-20 09:13AM	Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines? Zacks
Jan-17-20 08:27AM	Diabetes Management Gains FDA Attention: 3 Stocks in Focus Zacks
Jan-16-20 04:27PM	5 Top Stock Trades for Friday: SIG, MSFT, TNDM InvestorPlace
Jan-15-20 04:05PM	Tandem Diabetes Care Announces Commercial Launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States Business Wire
04:53AM	Announcing: Tandem Diabetes Care (NASDAQ:TNDM) Stock Increased An Energizing 164% In The Last Three Years Simply Wall St.
Jan-09-20 04:15PM	Tandem Diabetes Care Appoints New Executive Vice President of Strategy and Corporate Development Business Wire +5.46%
Dec-26-19 11:58AM	Hedge Fund Consensus Stocks vs. Tandem Diabetes Care Inc (TNDM) In 2019 Insider Monkey
11:42AM	Strong Pipeline Aids Tandem Diabetes Despite Stiff Rivalry Zacks
Dec-24-19 09:02AM	6 MedTech Stocks That are Set to Beat the Market in 2020 Zacks
Dec-19-19 07:04AM	Tandem Diabetes Sees Hammer Chart Pattern: Time to Buy? Zacks
Dec-16-19 03:55PM	5 Health Care Stocks Gurus Are Buying GuruFocus.com
11:22AM	Tandem Diabetes Gets FDA Nod for t:slim X2 Insulin Pump Zacks
Dec-13-19 01:36PM	Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology Business Wire +5.32%
Dec-03-19 04:06PM	Hedge Funds Have Never Been This Bullish On Tandem Diabetes Care Inc (TNDM) Insider Monkey
Nov-28-19 08:14AM	Digital Diabetes Management Gains Momentum: 3 Stocks in Focus Zacks
Nov-26-19 09:38AM	Here's Why You Should Buy Tandem Diabetes (TNDM) Stock Now Zacks
06:14AM	Will Tandem Diabetes Continue to Surge Higher? Zacks
Nov-21-19 12:22PM	Tandem Diabetes Gets Canadian Nod for t:slim X2 Insulin Pump Zacks
Nov-20-19 09:00AM	Tandem Diabetes Care Announces Health Canada Approval of t:slim X2 Insulin Pump with Basal-IQ Predictive Low-Glucose Suspend Technology Business Wire
Nov-08-19 10:55PM	Edited Transcript of TNDM earnings conference call or presentation 4-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
04:05PM	Tandem Diabetes Care Announces Upcoming Conference Presentations Business Wire
02:15PM	Tandem Diabetes Says Death Of Patient Wasn't Due To Insulin Pump Malfunction Benzinga
Nov-06-19 07:30AM	Using Gamma to Find Trade Ideas Schaeffer's Investment Research

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin delivery system with Basal-IQ Technology; t:slim X2 with control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Further, the company offers Sugarmate, a mobile app for people with diabetes who use insulin. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jul 06	Option Exercise	18.86	10,000	188,600	14,520	Jul 07 04:39 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jul 06	Option Exercise	2.59	2,000	5,180	5,886	Jul 07 04:40 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jul 06	Sale	101.65	2,000	203,310	4,566	Jul 07 04:40 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jul 06	Sale	105.04	10,000	1,050,387	4,520	Jul 07 04:39 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jul 02	Option Exercise	10.71	10,000	107,137	12,782	Jul 02 06:19 PM
TWOMEY CHRISTOPHER J	Director	Jul 02	Sale	100.28	7,500	752,074	20,000	Jul 07 04:40 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jul 02	Sale	100.44	10,000	1,004,355	4,520	Jul 02 06:19 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jun 30	Option Exercise	2.59	10,000	25,900	14,520	Jul 02 06:19 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jun 30	Sale	95.04	10,000	950,394	4,520	Jul 02 06:19 PM
BLICKENSTAFF KIM D	Director	Jun 30	Sale	95.57	50,000	4,778,401	584,593	Jul 02 06:20 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jun 03	Option Exercise	2.59	2,000	5,180	6,566	Jun 04 04:33 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jun 03	Sale	81.81	2,000	163,623	4,566	Jun 04 04:33 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	May 07	Option Exercise	2.59	10,000	25,900	13,265	May 08 04:23 PM
TWOMEY CHRISTOPHER J	Director	May 07	Sale	90.03	7,500	675,215	22,500	May 08 04:24 PM
Allen Dick	Director	May 07	Sale	89.00	3,500	311,500	1,000	May 08 04:25 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	May 07	Sale	90.07	10,000	900,746	3,265	May 08 04:23 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	May 04	Option Exercise	2.59	2,000	5,180	4,661	May 04 06:13 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	May 04	Sale	78.33	2,000	156,650	3,311	May 04 06:13 PM
TWOMEY CHRISTOPHER J	Director	Apr 30	Sale	80.00	4,308	344,640	25,000	May 04 06:12 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Apr 06	Option Exercise	2.59	2,000	5,180	5,311	Apr 08 04:18 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Apr 06	Sale	67.59	2,000	135,180	3,311	Apr 08 04:18 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Mar 03	Option Exercise	2.59	2,000	5,180	5,311	Mar 04 04:49 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Mar 03	Sale	77.16	2,000	154,329	3,311	Mar 04 04:49 PM
Allen Dick	Director	Feb 26	Option Exercise	73.73	3,184	234,756	39,778	Feb 28 06:03 PM
Allen Dick	Director	Feb 26	Sale	78.82	2,979	234,805	10,026	Feb 28 06:03 PM
Sheridan John F	PRESIDENT & CEO	Feb 21	Option Exercise	2.59	30,000	77,700	32,501	Feb 24 04:35 PM
Sheridan John F	PRESIDENT & CEO	Feb 21	Sale	87.86	30,000	2,635,887	2,501	Feb 24 04:35 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Feb 13	Option Exercise	2.59	16,000	41,440	19,311	Feb 14 04:16 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Feb 13	Sale	82.67	16,000	1,322,693	3,311	Feb 14 04:16 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Feb 11	Option Exercise	2.59	3,626	9,391	6,891	Feb 12 04:16 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Feb 11	Sale	80.00	3,626	290,080	3,265	Feb 12 04:16 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Feb 10	Option Exercise	2.59	6,374	16,509	9,639	Feb 12 04:16 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Feb 10	Sale	80.06	6,374	510,273	3,265	Feb 12 04:16 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Feb 03	Option Exercise	2.59	2,000	5,180	5,311	Feb 04 04:10 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Feb 03	Sale	75.46	2,000	150,912	3,311	Feb 04 04:10 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Jan 30	Option Exercise	18.86	20,945	395,023	23,936	Jan 31 06:27 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Jan 30	Sale	77.62	20,945	1,625,652	2,991	Jan 31 06:27 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jan 29	Option Exercise	2.59	12,000	31,080	15,311	Jan 31 05:21 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jan 29	Option Exercise	2.59	10,000	25,900	12,882	Jan 31 05:23 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Jan 29	Option Exercise	18.86	29,055	547,977	17,991	Jan 31 06:27 PM
Allen Dick	Director	Jan 29	Option Exercise	6.64	10,371	68,825	5,300	Jan 31 06:28 PM
Allen Dick	Director	Jan 29	Sale	75.93	10,371	787,451	0	Jan 31 06:28 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Jan 29	Sale	74.49	29,055	2,164,445	2,991	Jan 31 06:27 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Jan 29	Sale	75.93	10,000	759,253	3,265	Jan 31 05:23 PM
BLICKENSTAFF KIM D	Executive Chairman	Jan 29	Sale	75.92	50,000	3,796,125	641,750	Jan 31 05:22 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jan 29	Sale	74.62	12,000	895,470	3,311	Jan 31 05:21 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Jan 16	Option Exercise	0.00	10,000	0	12,991	Jan 17 06:57 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jan 16	Option Exercise	2.59	8,000	20,720	11,311	Jan 17 06:59 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Jan 16	Sale	69.76	10,000	697,620	2,991	Jan 17 06:57 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Jan 16	Sale	67.83	8,000	542,640	3,311	Jan 17 06:59 PM
BLICKENSTAFF KIM D	Executive Chairman	Dec 16	Sale	59.85	200,000	11,970,491	691,750	Dec 18 04:26 PM
Sheridan John F	PRESIDENT & CEO	Nov 25	Option Exercise	2.59	462	1,197	2,963	Nov 26 07:36 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Nov 25	Option Exercise	2.59	10,000	25,900	13,265	Nov 26 07:38 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Nov 25	Sale	70.35	10,000	703,500	3,265	Nov 26 07:38 PM
Sheridan John F	PRESIDENT & CEO	Nov 25	Sale	70.00	462	32,340	2,501	Nov 26 07:36 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Nov 18	Option Exercise	2.59	10,000	25,900	13,265	Nov 18 07:12 PM
Vosseller Leigh	EVP & CHIEF FINANCIAL OFFICER	Nov 18	Sale	65.41	10,000	654,128	3,265	Nov 18 07:12 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Nov 04	Option Exercise	2.59	15,000	38,850	17,991	Nov 06 05:13 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Nov 04	Sale	62.01	15,000	930,131	2,991	Nov 06 05:13 PM
Sheridan John F	PRESIDENT & CEO	Sep 06	Option Exercise	2.59	9,538	24,703	12,039	Sep 09 04:20 PM
Sheridan John F	PRESIDENT & CEO	Sep 06	Sale	70.03	9,538	667,946	2,501	Sep 09 04:20 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Sep 03	Option Exercise	2.59	2,000	5,180	5,311	Sep 03 07:27 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Sep 03	Sale	72.00	2,000	144,000	3,311	Sep 03 07:27 PM
BLICKENSTAFF KIM D	Executive Chairman	Aug 29	Sale	71.01	80,000	5,680,800	891,750	Aug 30 04:19 PM
BLICKENSTAFF KIM D	Executive Chairman	Aug 28	Sale	70.77	20,000	1,415,400	971,750	Aug 30 04:19 PM
ROEDER DOUGLAS A	Director	Aug 28	Sale	70.47	185,088	13,043,807	9,670	Aug 29 07:56 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Aug 27	Option Exercise	18.86	6,969	131,435	9,960	Aug 28 04:09 PM
ROEDER DOUGLAS A	Director	Aug 27	Sale	70.10	123,209	8,636,569	11,460	Aug 29 07:56 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Aug 27	Sale	70.00	6,969	487,830	2,991	Aug 28 04:09 PM
CAHILL EDWARD L	Director	Aug 13	Option Exercise	2.54	1,417	3,599	5,399	Aug 14 04:06 PM
CAHILL EDWARD L	Director	Aug 13	Sale	63.03	1,417	89,314	3,982	Aug 14 04:06 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Aug 12	Option Exercise	2.59	15,000	38,850	17,991	Aug 13 04:53 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Aug 12	Sale	62.97	15,000	944,550	2,991	Aug 13 04:53 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Aug 05	Option Exercise	2.59	2,000	5,180	5,311	Aug 06 04:17 PM
GREENE HOWARD E JR	Director	Aug 05	Sale	61.50	10,000	615,038	30,000	Aug 06 04:13 PM
BERGER DAVID B	EVP, Chief Legal & Compliance	Aug 05	Sale	62.56	2,000	125,120	3,311	Aug 06 04:17 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Aug 02	Option Exercise	18.86	5,000	94,300	7,991	Aug 06 04:14 PM
HANSEN BRIAN B	EVP & CHIEF COMMERCIAL OFFICER	Aug 02	Sale	70.01	5,000	350,050	2,991	Aug 06 04:14 PM
ROEDER DOUGLAS A	Director	Aug 02	Sale	70.01	9,471	663,076	12,651	Aug 06 06:54 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience